Literature DB >> 2050749

Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus.

F A Welsh1, V A Harris.   

Abstract

The objective of this study was to determine whether postischemic hypothermia diminishes ischemic injury in gerbil hippocampus. Cerebral ischemia was produced by occluding both carotid arteries for 5 min, while maintaining the temperature of the cranium and rectum at 38 degrees C. Upon recirculation, the animals were divided into three groups: normothermic (38 degrees C), moderately hypothermic (33 degrees C), and deeply hypothermic (23 degrees C). In the normothermic group, cranial and rectal temperatures were maintained at 38 degrees C for 30 min and 2 h, respectively, prior to the removal of the temperature probes. In the moderately hypothermic group, cranial and rectal temperatures were reduced within 10 min to 33 degrees C for 1 h, and then rewarmed to 38 degrees C. In the deeply hypothermic group, rectal temperature was lowered within 10 min to 23 degrees C for 2 h prior to rewarming to 38 degrees C. After recovery for 1 week, the extent of histologic injury in the hippocampus was assessed in stained sections. Maximal injury was present in the CA1 subfield in all three groups. These results indicate that hippocampal injury was not diminished by postischemic hypothermia during the first 2 h of reperfusion. Thus, pharmacologic studies of postischemic protection in the gerbil model may not be strongly influenced by transient postischemic hypothermia.

Entities:  

Mesh:

Year:  1991        PMID: 2050749     DOI: 10.1038/jcbfm.1991.112

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  11 in total

1.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Posthypoxic cooling of neonatal rats provides protection against brain injury.

Authors:  M Thoresen; R Bågenholm; E M Løberg; F Apricena; I Kjellmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 3.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

4.  The effect of hypothermia on induction of heat shock protein (HSP)-72 in ischemic brain.

Authors:  K Kumar; X Wu; A T Evans; F Marcoux
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

5.  Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.

Authors:  D G MacGregor; T W Stone
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Re-evaluation of ischemia-induced neuronal damage in hippocampal regions in the normothermic gerbil.

Authors:  Y Andou; A Mitani; S Masuda; T Arai; K Kataoka
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Drugs acting on calcium channels: potential treatment for ischaemic stroke.

Authors:  B J Alps
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

8.  Poor correlation between delayed neuronal death induced by transient forebrain ischemia, and immunoreactivity for parvalbumin and calbindin D-28k in developing gerbil hippocampus.

Authors:  A Tortosa; I Ferrer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia.

Authors:  C Coimbra; T Wieloch
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents.

Authors:  B J Alps; C Calder; A D Wilson; D E McBean; J M Armstrong
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.